Using vitamin D (both native and active forms) and paracalcitol (a selective VDR activator) may help reduce inflammation and improve anemia in CKD subjects, potentially lowering the doses of Epo required to achieve the same effect on erythropoiesis [110]. Here, EPO is linked to anemia (phenotype).